What is he best known for?
The fields of study he is best known for:
- Antibody
- Cancer
- Immune system
Philip O. Livingston focuses on Immunology, Antigen, Antibody, Adjuvant and Immune system.
His work is connected to Keyhole limpet hemocyanin, Immunotherapy, Immunogenicity, Conjugate vaccine and Vaccination, as a part of Immunology.
His work deals with themes such as Epitope, QS21 and Antibody titer, which intersect with Keyhole limpet hemocyanin.
In his work, Ganglioside, Phases of clinical research and Concomitant is strongly intertwined with Melanoma, which is a subfield of Immunotherapy.
His work carried out in the field of Antigen brings together such families of science as Cancer, Prostate cancer, Monoclonal antibody and Pathology.
Philip O. Livingston interconnects Titer, Cellular immunity, Immunization, Humoral immunity and Ganglioside GM2 in the investigation of issues within Adjuvant.
His most cited work include:
- Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens (286 citations)
- Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides (275 citations)
- Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man (223 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Antibody, Antigen, Immunology, Adjuvant and Keyhole limpet hemocyanin.
His Antibody research incorporates elements of Molecular biology, Cancer, Immune system and Ganglioside.
His study looks at the relationship between Cancer and fields such as Cancer research, as well as how they intersect with chemical problems.
His work on Epitope as part of general Antigen research is frequently linked to Glycopeptide, thereby connecting diverse disciplines of science.
His research investigates the connection between Immunology and topics such as Melanoma that intersect with issues in Internal medicine and Human leukocyte antigen.
His study looks at the relationship between Adjuvant and topics such as Pharmacology, which overlap with Toxicity.
He most often published in these fields:
- Antibody (48.44%)
- Antigen (47.40%)
- Immunology (44.79%)
What were the highlights of his more recent work (between 2008-2019)?
- Antigen (47.40%)
- Adjuvant (33.33%)
- Antibody (48.44%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Antigen, Adjuvant, Antibody, Monoclonal antibody and Immunology.
His Antigen research is multidisciplinary, incorporating elements of Cancer vaccine, Biochemistry, In vivo and Virology.
His studies in Adjuvant integrate themes in fields like Immune system, Toxicity, Natural product, Pharmacology and Conjugate vaccine.
His study of Keyhole limpet hemocyanin is a part of Antibody.
His Monoclonal antibody research incorporates themes from Cancer, Cancer research, Complement system and Molecular biology.
His research in Immunology intersects with topics in Melanoma and Cytotoxicity.
Between 2008 and 2019, his most popular works were:
- Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. (113 citations)
- A High-Throughput O-Glycopeptide Discovery Platform for Seromic Profiling (73 citations)
- Design and Synthesis of Potent Quillaja Saponin Vaccine Adjuvants (66 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Antibody
- Immune system
The scientist’s investigation covers issues in Adjuvant, Antibody, Pharmacology, Immune system and Antigen.
Philip O. Livingston has researched Adjuvant in several fields, including Trisaccharide, Biochemistry and Carboxylic acid.
His Antibody study results in a more complete grasp of Immunology.
His Keyhole limpet hemocyanin, Hemocyanin and Immunization study in the realm of Immunology connects with subjects such as Polysialic acid and Minimal residual disease.
The Pharmacology study combines topics in areas such as Natural product and Toxicity.
His Monoclonal antibody study combines topics in areas such as Circulating biomarkers, Peripheral blood mononuclear cell, In vivo and Cytotoxicity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
